43769 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 09
00:49 UTC
|
DXPE
DXP Enterprises
|
◎ Target | Tommy Moll ★★★★☆ #561 | Overweight | $160.00→ $220.00+37.5% |
|
Aug 09
00:49 UTC
|
DVA
DaVita
|
◎ Target | David MacDonald not yet tracked | Hold | $250.00→ $215.00-14.0% |
|
Aug 09
00:49 UTC
|
DUOL
Duolingo
|
◎ Target | Alec Brondolo ★★★☆☆ #1489 | Underweight | $82.00→ $80.00-2.4% |
|
Aug 09
00:49 UTC
|
DRVN
Driven Brands
|
◎ Target | Steven Shemesh ★★★☆☆ #999 | Outperform | $17.00→ $16.00-5.9% |
|
Aug 09
00:49 UTC
|
DOCS
Doximity
|
◎ Target | Alexei Gogolev ★★★★☆ #565 | Neutral | $26.00→ $31.00+19.2% |
|
Aug 09
00:49 UTC
|
DNOW
DNOW
|
◎ Target | Charles Minervino ★★★☆☆ #1280 | Positive | $16.00→ $19.00+18.8% |
|
Aug 09
00:49 UTC
|
DNLI
Denali Therapeutics
|
◎ Target | Michael Yee ★★★☆☆ #1570 | Buy | $25.00→ $34.00+36.0% |
|
Aug 09
00:49 UTC
|
DKNG
DraftKings
|
◎ Target | Mike Hickey ★★★☆☆ #1938 | Buy | $29.00→ $30.00+3.4% |
|
Aug 09
00:49 UTC
|
DII.B
Dorel Industries
|
◎ Target | firm only | Hold | C$2.00→ C$1.50-25.0% |
|
Aug 09
00:49 UTC
|
DEI
Douglas Emmett
|
◎ Target | Richard Anderson ★★★★☆ #573 | Neutral | $12.00→ $13.00+8.3% |
|
Aug 09
00:49 UTC
|
DDOG
Datadog
|
◎ Target | Karl Keirstead ★★★☆☆ #1040 | Buy | $315.00→ $280.00-11.1% |
|
Aug 09
00:49 UTC
|
DDOG
Datadog
|
◎ Target | Mike Cikos ★★★★★ #79 | Buy | $260.00→ $300.00+15.4% |
|
Aug 09
00:49 UTC
|
DDOG
Datadog
|
◎ Target | Fatima Boolani ★★★★☆ #370 | Buy | $300.00→ $305.00+1.7% |
|
Aug 09
00:49 UTC
|
DD
DuPont de Nemours
|
◎ Target | Arun Viswanathan ★★★☆☆ #1178 | Outperform | $180.00→ $176.00-2.2% |
|
Aug 09
00:49 UTC
|
DCO
Ducommun
|
◎ Target | Ken Herbert not yet tracked | Sec→ r Perform ➝ Sector Performer | $175.00→ $200.00+14.3% |
|
Aug 09
00:49 UTC
|
DBX
Dropbox
|
◎ Target | Steven Enders not yet tracked | Neutral | $28.00→ $33.00+17.9% |
|
Aug 09
00:49 UTC
|
DASH
DoorDash
|
◎ Target | Shyam Patil ★★★★★ #265 | Positive | $225.00→ $250.00+11.1% |
|
Aug 09
00:49 UTC
|
DASH
DoorDash
|
◎ Target | Ken Gawrelski ★★★☆☆ #1379 | Equal Weight | $199.00→ $225.00+13.1% |
|
Aug 09
00:49 UTC
|
DAN
Dana
|
◎ Target | Colin Langan ★★★☆☆ #1908 | Equal Weight | $33.00→ $28.00-15.2% |
|
Aug 09
00:49 UTC
|
DAN
Dana
|
◎ Target | Joseph Spak ★★★☆☆ #1502 | Buy | $39.00→ $38.00-2.6% |
|
Aug 09
00:49 UTC
|
DAN
Dana
|
◎ Target | Tom Narayan ★★★☆☆ #1693 | Outperform | $33.00→ $37.00+12.1% |
|
Aug 09
00:49 UTC
|
CYTK
Cytokinetics
|
◎ Target | Leonid Timashev ★★★☆☆ #1253 | Outperform | $117.00→ $112.00-4.3% |
|
Aug 09
00:49 UTC
|
CYTK
Cytokinetics
|
◎ Target | Jason N. Butler not yet tracked | Market Outperform | $105.00→ $110.00+4.8% |
|
Aug 09
00:49 UTC
|
CYTK
Cytokinetics
|
◎ Target | Serge Belanger ★★★☆☆ #1010 | Buy | $102.00→ $112.00+9.8% |
|
Aug 09
00:49 UTC
|
CYRX
CryoPort
|
◎ Target | Subbu Nambi ★★★★★ #172 | Buy | $12.00→ $16.00+33.3% |
|
Aug 09
00:49 UTC
|
CYRX
CryoPort
|
◎ Target | David Saxon ★★★★★ #280 | Buy | $15.00→ $19.00+26.7% |
|
Aug 09
00:49 UTC
|
CXW
CoreCivic
|
◎ Target | Bill Sutherland ★★★★☆ #599 | Buy | $41.00→ $45.00+9.8% |
|
Aug 09
00:49 UTC
|
CRL
Charles River Laboratories International
|
◎ Target | Ricky Goldwasser not yet tracked | Overweight | $260.00→ $300.00+15.4% |
|
Aug 09
00:49 UTC
|
CRBP
Corbus Pharmaceuticals
|
◎ Target | Andres Y. Maldonado ★★☆☆☆ #2332 | Buy | $40.00→ $35.00-12.5% |
|
Aug 09
00:49 UTC
|
CRBP
Corbus Pharmaceuticals
|
◎ Target | Jeff Jones ★★☆☆☆ #2693 | Outperform | $52.00→ $48.00-7.7% |
|
Aug 09
00:49 UTC
|
CQP
Cheniere Energy Partners
|
◎ Target | Theresa Chen ★★★☆☆ #1183 | Underweight | $63.00→ $66.00+4.8% |
|
Aug 09
00:49 UTC
|
COR
Cencora
|
◎ Target | Erin Wright ★★★★☆ #409 | Overweight | $342.00→ $346.00+1.2% |
|
Aug 09
00:49 UTC
|
COR
Cencora
|
◎ Target | Lisa Gill ★★★★★ #230 | Overweight | $382.00→ $390.00+2.1% |
|
Aug 09
00:49 UTC
|
COP
ConocoPhillips
|
◎ Target | Sam Margolin ★★★☆☆ #2157 | Overweight | $183.00→ $189.00+3.3% |
|
Aug 09
00:49 UTC
|
CNQ
Canadian Natural Resources
|
◎ Target | firm only | Outperform | C$65.00→ C$66.00+1.5% |
|
Aug 09
00:49 UTC
|
CNQ
Canadian Natural Resources
|
◎ Target | firm only | Buy | C$72.00→ C$73.00+1.4% |
|
Aug 09
00:49 UTC
|
CNQ
Canadian Natural Resources
|
◎ Target | firm only | Sec→ r Perform | C$71.00→ C$73.00+2.8% |
|
Aug 09
00:49 UTC
|
CMPX
Compass Therapeutics
|
◎ Target | Biren Amin ★☆☆☆☆ #3005 | Overweight | $4.00→ $6.00+50.0% |
|
Aug 09
00:49 UTC
|
CMPS
Compass Pathways
|
◎ Target | Patrick R. Trucchio not yet tracked | Buy | $70.00→ $65.00-7.1% |
|
Aug 09
00:49 UTC
|
CMC
Commercial Metals
|
◎ Target | Richard Garchitorena ★★★☆☆ #1986 | Equal Weight | $75.00→ $80.00+6.7% |
|
Aug 09
00:49 UTC
|
CLYM
Climb Bio
|
◎ Target | Danielle Brill ★★★☆☆ #1364 | Buy | $17.00→ $25.00+47.1% |
|
Aug 09
00:49 UTC
|
CLS
Celestica
|
◎ Target | Tim Long ★★★☆☆ #1596 | Overweight | $430.00→ $406.00-5.6% |
|
Aug 09
00:49 UTC
|
CLDX
Celldex Therapeutics
|
◎ Target | Etzer Darout ★★★☆☆ #1100 | Overweight | $48.00→ $53.00+10.4% |
|
Aug 09
00:49 UTC
|
CLDX
Celldex Therapeutics
|
◎ Target | Judah Frommer ★★★☆☆ #1682 | Overweight | $40.00→ $46.00+15.0% |
|
Aug 09
00:49 UTC
|
CIFR
Cipher Mining
|
◎ Target | Richard Choe ★☆☆☆☆ #2984 | Overweight | $23.00→ $22.00-4.3% |
|
Aug 09
00:49 UTC
|
CHYM
Chime Financial
|
◎ Target | Nik Cremo ★☆☆☆☆ #3123 | Overweight | $26.00→ $33.00+26.9% |
|
Aug 09
00:49 UTC
|
CGON
CG Oncology
|
◎ Target | Leonid Timashev ★★★☆☆ #1253 | Outperform | $81.00→ $79.00-2.5% |
|
Aug 09
00:49 UTC
|
CGON
CG Oncology
|
◎ Target | Kelsey Goodwin ★★☆☆☆ #2460 | Overweight | $82.00→ $85.00+3.7% |
|
Aug 09
00:49 UTC
|
CGON
CG Oncology
|
◎ Target | Gregory Renza ★★★☆☆ #1450 | Buy | $82.00→ $85.00+3.7% |
|
Aug 09
00:49 UTC
|
CGNX
Cognex
|
◎ Target | Jamie Cook ★★★☆☆ #2060 | Hold | $71.00→ $78.00+9.9% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.